Estrogen receptors α and β as determinants of gene expression: Influence of ligand, dose, and chromatin binding

Edmund C. Chang, Tze Howe Charn, Sung Hee Park, William G Helferich, Barry Komm, John A. Katzenellenbogen, Benita S Katzenellenbogen

Research output: Contribution to journalArticle

Abstract

Estrogen receptors α and β (ERα and ERβ) mediate the actions of estrogens in a variety of normal and cancer target cells. Estrogens differ in their preference for these ERs, and many phytoestrogens bind preferentially to ERβ. To investigate how phytoestrogens such as genistein impact ER-regulated gene expression, we used adenoviral gene delivery of ERβ coupled with ERα depletion with small interfering RNA to generate human breast cancer (MCF-7) cells expressing four complements of ERα and ERβ. We examined the dose-dependent effects of genistein on genome-wide gene expression by DNA microarrays and monitored the recruitment of ERs and coregulators to responsive regions of estrogen-regulated genes. At a low (6 nM) concentration, genistein regulated gene expression much more effectively in cells coexpressing ERα and ERβ than in cells expressing ERα alone, whereas at high concentration (300 nM), genistein induced transcriptome changes very similar to that of 17β-estradiol. We demonstrate that ERβ is preferentially activated by genistein and is recruited to estrogen-responsive genomic sites and that differential occupancy of ERα and ERβ by genistein and 17β-estradiol in turn influences the recruitment patterns of coregulators such as steroid receptor coactivator 3 (SRC3) and receptor-interacting protein 140 (RIP140). Our observations indicate that genistein is a potency-selective ligand for gene expression regulation by ERα and ERβ and that the ability of ERα and ERβ to serve as determinants of gene expression is greatly influenced by the nature of the ligand, by ligand dose, and by the differential abilities of ligand-ER complexes to recruit different coregulators at ER binding sites of hormone-regulated genes.

Original languageEnglish (US)
Pages (from-to)1032-1043
Number of pages12
JournalMolecular Endocrinology
Volume22
Issue number5
DOIs
StatePublished - May 1 2008

Fingerprint

Genistein
Estrogen Receptors
Chromatin
Ligands
Gene Expression
Estrogens
Phytoestrogens
Nuclear Receptor Co-Repressor 1
Nuclear Receptor Coactivator 3
Estradiol
Genes
MCF-7 Cells
Gene Expression Regulation
Oligonucleotide Array Sequence Analysis
Transcriptome
Small Interfering RNA
Binding Sites
Genome
Hormones
Breast Neoplasms

ASJC Scopus subject areas

  • Molecular Biology
  • Endocrinology

Cite this

Estrogen receptors α and β as determinants of gene expression : Influence of ligand, dose, and chromatin binding. / Chang, Edmund C.; Charn, Tze Howe; Park, Sung Hee; Helferich, William G; Komm, Barry; Katzenellenbogen, John A.; Katzenellenbogen, Benita S.

In: Molecular Endocrinology, Vol. 22, No. 5, 01.05.2008, p. 1032-1043.

Research output: Contribution to journalArticle

Chang, Edmund C. ; Charn, Tze Howe ; Park, Sung Hee ; Helferich, William G ; Komm, Barry ; Katzenellenbogen, John A. ; Katzenellenbogen, Benita S. / Estrogen receptors α and β as determinants of gene expression : Influence of ligand, dose, and chromatin binding. In: Molecular Endocrinology. 2008 ; Vol. 22, No. 5. pp. 1032-1043.
@article{452996feec404a599e5f57a487624840,
title = "Estrogen receptors α and β as determinants of gene expression: Influence of ligand, dose, and chromatin binding",
abstract = "Estrogen receptors α and β (ERα and ERβ) mediate the actions of estrogens in a variety of normal and cancer target cells. Estrogens differ in their preference for these ERs, and many phytoestrogens bind preferentially to ERβ. To investigate how phytoestrogens such as genistein impact ER-regulated gene expression, we used adenoviral gene delivery of ERβ coupled with ERα depletion with small interfering RNA to generate human breast cancer (MCF-7) cells expressing four complements of ERα and ERβ. We examined the dose-dependent effects of genistein on genome-wide gene expression by DNA microarrays and monitored the recruitment of ERs and coregulators to responsive regions of estrogen-regulated genes. At a low (6 nM) concentration, genistein regulated gene expression much more effectively in cells coexpressing ERα and ERβ than in cells expressing ERα alone, whereas at high concentration (300 nM), genistein induced transcriptome changes very similar to that of 17β-estradiol. We demonstrate that ERβ is preferentially activated by genistein and is recruited to estrogen-responsive genomic sites and that differential occupancy of ERα and ERβ by genistein and 17β-estradiol in turn influences the recruitment patterns of coregulators such as steroid receptor coactivator 3 (SRC3) and receptor-interacting protein 140 (RIP140). Our observations indicate that genistein is a potency-selective ligand for gene expression regulation by ERα and ERβ and that the ability of ERα and ERβ to serve as determinants of gene expression is greatly influenced by the nature of the ligand, by ligand dose, and by the differential abilities of ligand-ER complexes to recruit different coregulators at ER binding sites of hormone-regulated genes.",
author = "Chang, {Edmund C.} and Charn, {Tze Howe} and Park, {Sung Hee} and Helferich, {William G} and Barry Komm and Katzenellenbogen, {John A.} and Katzenellenbogen, {Benita S}",
year = "2008",
month = "5",
day = "1",
doi = "10.1210/me.2007-0356",
language = "English (US)",
volume = "22",
pages = "1032--1043",
journal = "Molecular Endocrinology",
issn = "0888-8809",
publisher = "The Endocrine Society",
number = "5",

}

TY - JOUR

T1 - Estrogen receptors α and β as determinants of gene expression

T2 - Influence of ligand, dose, and chromatin binding

AU - Chang, Edmund C.

AU - Charn, Tze Howe

AU - Park, Sung Hee

AU - Helferich, William G

AU - Komm, Barry

AU - Katzenellenbogen, John A.

AU - Katzenellenbogen, Benita S

PY - 2008/5/1

Y1 - 2008/5/1

N2 - Estrogen receptors α and β (ERα and ERβ) mediate the actions of estrogens in a variety of normal and cancer target cells. Estrogens differ in their preference for these ERs, and many phytoestrogens bind preferentially to ERβ. To investigate how phytoestrogens such as genistein impact ER-regulated gene expression, we used adenoviral gene delivery of ERβ coupled with ERα depletion with small interfering RNA to generate human breast cancer (MCF-7) cells expressing four complements of ERα and ERβ. We examined the dose-dependent effects of genistein on genome-wide gene expression by DNA microarrays and monitored the recruitment of ERs and coregulators to responsive regions of estrogen-regulated genes. At a low (6 nM) concentration, genistein regulated gene expression much more effectively in cells coexpressing ERα and ERβ than in cells expressing ERα alone, whereas at high concentration (300 nM), genistein induced transcriptome changes very similar to that of 17β-estradiol. We demonstrate that ERβ is preferentially activated by genistein and is recruited to estrogen-responsive genomic sites and that differential occupancy of ERα and ERβ by genistein and 17β-estradiol in turn influences the recruitment patterns of coregulators such as steroid receptor coactivator 3 (SRC3) and receptor-interacting protein 140 (RIP140). Our observations indicate that genistein is a potency-selective ligand for gene expression regulation by ERα and ERβ and that the ability of ERα and ERβ to serve as determinants of gene expression is greatly influenced by the nature of the ligand, by ligand dose, and by the differential abilities of ligand-ER complexes to recruit different coregulators at ER binding sites of hormone-regulated genes.

AB - Estrogen receptors α and β (ERα and ERβ) mediate the actions of estrogens in a variety of normal and cancer target cells. Estrogens differ in their preference for these ERs, and many phytoestrogens bind preferentially to ERβ. To investigate how phytoestrogens such as genistein impact ER-regulated gene expression, we used adenoviral gene delivery of ERβ coupled with ERα depletion with small interfering RNA to generate human breast cancer (MCF-7) cells expressing four complements of ERα and ERβ. We examined the dose-dependent effects of genistein on genome-wide gene expression by DNA microarrays and monitored the recruitment of ERs and coregulators to responsive regions of estrogen-regulated genes. At a low (6 nM) concentration, genistein regulated gene expression much more effectively in cells coexpressing ERα and ERβ than in cells expressing ERα alone, whereas at high concentration (300 nM), genistein induced transcriptome changes very similar to that of 17β-estradiol. We demonstrate that ERβ is preferentially activated by genistein and is recruited to estrogen-responsive genomic sites and that differential occupancy of ERα and ERβ by genistein and 17β-estradiol in turn influences the recruitment patterns of coregulators such as steroid receptor coactivator 3 (SRC3) and receptor-interacting protein 140 (RIP140). Our observations indicate that genistein is a potency-selective ligand for gene expression regulation by ERα and ERβ and that the ability of ERα and ERβ to serve as determinants of gene expression is greatly influenced by the nature of the ligand, by ligand dose, and by the differential abilities of ligand-ER complexes to recruit different coregulators at ER binding sites of hormone-regulated genes.

UR - http://www.scopus.com/inward/record.url?scp=43049090857&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43049090857&partnerID=8YFLogxK

U2 - 10.1210/me.2007-0356

DO - 10.1210/me.2007-0356

M3 - Article

C2 - 18258689

AN - SCOPUS:43049090857

VL - 22

SP - 1032

EP - 1043

JO - Molecular Endocrinology

JF - Molecular Endocrinology

SN - 0888-8809

IS - 5

ER -